Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

South Korea · Delayed Price · Currency is KRW

4,990.00

+50.00 (1.01%)

At close: Nov 13, 2026

Market Cap	146.21B -5.8%
Revenue (ttm)	201.12B +3.5%
Net Income	17.83B +353.6%
EPS	647.56 +331.2%
Shares Out	29.30M
PE Ratio	7.71
Forward PE	n/a
Dividend	300.00 (6.01%)
Ex-Dividend Date	Dec 29, 2026

Volume	50,820
Open	4,920.00
Previous Close	4,940.00
Day's Range	4,920.00 - 5,020.00
52-Week Range	4,700.00 - 6,270.00
Beta	0.36
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Kyung Dong Pharmaceutical

Kyung Dong Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals in South Korea. The company offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, cardiovascular and dysplidemia, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, antihistamine, CNS, antiobesity, NVP, neuropathic, osteoporosis, respiratory, allergy, and arthrifuge categories. It also provi... [Read more]

Industry Pharmaceutical Preparations

Founded 1975

Employees 332

Stock Exchange KOSDAQ

Ticker Symbol 011040

Full Company Profile

Financial Performance

In 2025, Kyung Dong Pharmaceutical's revenue was 196.27 billion, an increase of 1.20% compared to the previous year's 193.94 billion. Earnings were 8.53 billion, an increase of 55.93%.

Financial Statements